Journal of Neuro-Oncology

, 91:199

Survival benefit of Boron neutron capture therapy for recurrent malignant gliomas

  • Shin-Ichi Miyatake
  • Shinji Kawabata
  • Kunio Yokoyama
  • Toshihiko Kuroiwa
  • Hiroyuki Michiue
  • Yoshinori Sakurai
  • Hiroaki Kumada
  • Minoru Suzuki
  • Akira Maruhashi
  • Mitsunori Kirihata
  • Koji Ono
Clinical study - patient Study

DOI: 10.1007/s11060-008-9699-x

Cite this article as:
Miyatake, S., Kawabata, S., Yokoyama, K. et al. J Neurooncol (2009) 91: 199. doi:10.1007/s11060-008-9699-x

Abstract

We have applied boron neutron capture therapy (BNCT) to malignant brain tumors. Here we evaluated the survival benefit of BNCT for recurrent malignant glioma (MG). Since 2002, we have treated 22 cases of recurrent MG with BNCT. Survival time was analyzed with special reference to recursive partitioning analysis (RPA) classification, by Carson et al. (J Clin Oncol 25:2601–2606, 2007). Median survival times (MSTs) after BNCT for all patients and for glioblastoma as on-study histology at recurrence was 10.8 months (n = 22; 95% CI, 7.3–12.8 months) and 9.6 months (n = 19; 95% CI, 6.9–11.4 months), respectively. In our study, MST for the high-risk RPA classes was 9.1 months (n = 11; 95% CI, 4.4–11.0 months). By contrast, the original journal data showed that the MST of the same RPA classes was 4.4 months (n = 129; 95% CI, 3.6–5.4 months). BNCT showed a survival benefit for recurrent MG, especially in the high-risk group.

Keywords

BNCTBPA–PETGBMMGRPA

Supplementary material

11060_2008_9699_MOESM1_ESM.doc (34 kb)
MOESM1 (DOC 33 kb)

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Shin-Ichi Miyatake
    • 1
    • 2
  • Shinji Kawabata
    • 1
  • Kunio Yokoyama
    • 1
  • Toshihiko Kuroiwa
    • 1
  • Hiroyuki Michiue
    • 3
  • Yoshinori Sakurai
    • 4
  • Hiroaki Kumada
    • 5
  • Minoru Suzuki
    • 4
  • Akira Maruhashi
    • 4
  • Mitsunori Kirihata
    • 6
  • Koji Ono
    • 4
  1. 1.Department of NeurosurgeryOsaka Medical CollegeTakatsukiJapan
  2. 2.Cancer Intelligence Care System, Inc.TokyoJapan
  3. 3.Department of NeurosurgeryOkayama UniversityOkayamaJapan
  4. 4.Particle Radiation Oncology Research Center, Research Reactor Institute, Kyoto UniversityKumatoriJapan
  5. 5.Department of Research Reactor and Tandem Accelerator, Nuclear Science Institute, Japan Atomic Energy AgencyTokaiJapan
  6. 6.Department of AgricultureOsaka Prefectural UniversitySakaiJapan